Abstract
Rifaximin Improves Cognitive Functions and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial (The RIME Trial)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have